Rubio Sidesteps Tariff Dispute in Manila Trade Talks

While the drug import policy failed to surface in this specific diplomatic dialogue, the initiative remains a cornerstone of the current administration’s strategy. Under the recently extended mandate, tariffs on generic medications will hold at zero until 2026 before rising sharply, a move designed to incentivize domestic production. The surge in new pharmaceutical facility construction across the United States signals that this policy is already reshaping local capacity.

Rubio and Jaishankar instead prioritized the finalization of an interim bilateral trade agreement. Their discussions also covered broader geopolitical stakes, specifically regarding the Indo-Pacific region and the volatile situation in West Asia. Despite the looming tariff escalation, the Indian government has yet to signal formal concern over the US-centric manufacturing push.